Skip to main content
Clinical Trials/NCT04007172
NCT04007172
Completed
Not Applicable

Effectiveness of Neural Therapy in Patients With Fibromiyalgia

Hitit University1 site in 1 country60 target enrollmentJanuary 20, 2019
ConditionsFibromyalgia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Hitit University
Enrollment
60
Locations
1
Primary Endpoint
Visual analog scale for pain
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Neural therapy is a regulation therapy that tries to correct this underlying autonomic dysfunction. In neural therapy; local painful areas, trigger points and symptomatic segments are included in the injection using local anesthetics and the underlying disruptive areas are investigated and treated. The aim of this study was to investigate the efficacy of neural therapy in fibromyalgia syndrome which is thought to have a neuroendocrine dysregulation disorder.

Detailed Description

Fibromyalgia is a chronic disease characterized by widespread body pain, fatigue, sleep disturbance, and tenderness on palpation at trigger points in the musculoskeletal system. Fibromyalgia prevalence is reported between 3% and 9%, and is three times more common in women than men. Although pharmacological and non-pharmacological approaches play a role in the treatment of the disease, the interest in non-pharmacological therapies has recently increased. In several studies, it has been shown that almost every fibromyalgia patient has applied at least one alternative and complementary medicine method such as Qigong, Tai Chi, yoga, mind body interventions, acupuncture, hydrotherapy, balneotherapy or phytotherapy. Neural therapy is a regulation therapy that tries to correct this underlying autonomic dysfunction. In neural therapy; local painful areas, trigger points and symptomatic segments are included in the injection using local anesthetics and the underlying disruptive areas are investigated and treated. The aim of this study was to investigate the efficacy of neural therapy in fibromyalgia syndrome which is thought to have a neuroendocrine dysregulation disorder.

Registry
clinicaltrials.gov
Start Date
January 20, 2019
End Date
May 14, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Hitit University
Responsible Party
Principal Investigator
Principal Investigator

Tuğba Atan

Assoc. Prof.

Hitit University

Eligibility Criteria

Inclusion Criteria

  • Subjects diagnosed according to the American College of Rheumatology 2016 diagnostic criteria for fibromyalgia.

Exclusion Criteria

  • History of comorbid inflammatory rheumatic/ connective tissue diseases
  • History of cardiovascular or musculoskeletal problems that could prevent them to participate in an exercise program

Outcomes

Primary Outcomes

Visual analog scale for pain

Time Frame: 4 weeks

Pain intensity was measured with visual analogue scale for pain (0-10 mm; 0 means no pain, 10 means severe pain) which is used to measure musculoskeletal pain with very good reliability and validity.

Secondary Outcomes

  • Short- form health survey 36 scores(4 weeks)
  • Fibromyalgia Impact Questionnaire(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials